肺静脉隔离与胺碘酮治疗并发持续性房颤和充血性心力衰竭患者的长期疗效比较。

IF 4.2 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiac Failure Review Pub Date : 2020-04-09 eCollection Date: 2020-03-01 DOI:10.15420/cfr.2019.03
Michela Faggioni, Domenico G Della Rocca, Sanghamitra Mohanty, Chintan Trivedi, Ugur Canpolat, Carola Gianni, Amin Al-Ahmad, Rodney Horton, Gerald Joseph Gallinghouse, John David Burkhardt, Andrea Natale
{"title":"肺静脉隔离与胺碘酮治疗并发持续性房颤和充血性心力衰竭患者的长期疗效比较。","authors":"Michela Faggioni,&nbsp;Domenico G Della Rocca,&nbsp;Sanghamitra Mohanty,&nbsp;Chintan Trivedi,&nbsp;Ugur Canpolat,&nbsp;Carola Gianni,&nbsp;Amin Al-Ahmad,&nbsp;Rodney Horton,&nbsp;Gerald Joseph Gallinghouse,&nbsp;John David Burkhardt,&nbsp;Andrea Natale","doi":"10.15420/cfr.2019.03","DOIUrl":null,"url":null,"abstract":"<p><p>Although pharmacological rhythm control of AF in patients with heart failure with reduced ejection fraction (HFrEF) does not seem to provide any benefit over rate control, catheter ablation of AF has been shown to improve clinical outcomes. These results can be explained with higher success rates of catheter ablation in restoring and maintaining sinus rhythm compared with antiarrhythmic drugs. In addition, pharmacotherapy is not void of side-effects, which are thought to offset its potential antiarrhythmic benefits. Therefore, efforts should be made towards optimisation of ablation techniques for AF in patients with HFrEF.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"6 ","pages":"e04"},"PeriodicalIF":4.2000,"publicationDate":"2020-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/b5/cfr-06-e04.PMC7199124.pdf","citationCount":"0","resultStr":"{\"title\":\"Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure.\",\"authors\":\"Michela Faggioni,&nbsp;Domenico G Della Rocca,&nbsp;Sanghamitra Mohanty,&nbsp;Chintan Trivedi,&nbsp;Ugur Canpolat,&nbsp;Carola Gianni,&nbsp;Amin Al-Ahmad,&nbsp;Rodney Horton,&nbsp;Gerald Joseph Gallinghouse,&nbsp;John David Burkhardt,&nbsp;Andrea Natale\",\"doi\":\"10.15420/cfr.2019.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Although pharmacological rhythm control of AF in patients with heart failure with reduced ejection fraction (HFrEF) does not seem to provide any benefit over rate control, catheter ablation of AF has been shown to improve clinical outcomes. These results can be explained with higher success rates of catheter ablation in restoring and maintaining sinus rhythm compared with antiarrhythmic drugs. In addition, pharmacotherapy is not void of side-effects, which are thought to offset its potential antiarrhythmic benefits. Therefore, efforts should be made towards optimisation of ablation techniques for AF in patients with HFrEF.</p>\",\"PeriodicalId\":33741,\"journal\":{\"name\":\"Cardiac Failure Review\",\"volume\":\"6 \",\"pages\":\"e04\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2020-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/b5/cfr-06-e04.PMC7199124.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiac Failure Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/cfr.2019.03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/3/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Failure Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/cfr.2019.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

尽管在心力衰竭伴射血分数降低(HFrEF)的患者中,房颤的药理学节律控制似乎没有提供任何优于心率控制的益处,但房颤的导管消融已被证明可以改善临床结果。这些结果可以解释与抗心律失常药物相比,导管消融在恢复和维持窦性心律方面的成功率更高。此外,药物治疗并非没有副作用,这些副作用被认为抵消了其潜在的抗心律失常益处。因此,应努力优化HFrEF患者房颤的消融技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure.

Although pharmacological rhythm control of AF in patients with heart failure with reduced ejection fraction (HFrEF) does not seem to provide any benefit over rate control, catheter ablation of AF has been shown to improve clinical outcomes. These results can be explained with higher success rates of catheter ablation in restoring and maintaining sinus rhythm compared with antiarrhythmic drugs. In addition, pharmacotherapy is not void of side-effects, which are thought to offset its potential antiarrhythmic benefits. Therefore, efforts should be made towards optimisation of ablation techniques for AF in patients with HFrEF.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
0.00%
发文量
31
审稿时长
9 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信